BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 17786704)

  • 1. Microbiome-intestine cross talk during acute graft-versus-host disease.
    Rafei H; Jenq RR
    Blood; 2020 Jul; 136(4):401-409. PubMed ID: 32526029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD24Fc to DAMPen GVHD.
    Martin PJ
    Blood; 2024 Jan; 143(1):1-2. PubMed ID: 38175676
    [No Abstract]   [Full Text] [Related]  

  • 3. GVHD: better safe than sorry.
    Bonifazi F
    Blood; 2023 Aug; 142(8):680-682. PubMed ID: 37616024
    [No Abstract]   [Full Text] [Related]  

  • 4. Targeting deacetylases to improve outcomes after allogeneic bone marrow transplantation.
    Reddy P
    Trans Am Clin Climatol Assoc; 2013; 124():152-62. PubMed ID: 23874019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HDAC inhibition and graft versus host disease.
    Choi S; Reddy P
    Mol Med; 2011; 17(5-6):404-16. PubMed ID: 21298214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the IL17 pathway for the prevention of graft-versus-host disease.
    van der Waart AB; van der Velden WJ; Blijlevens NM; Dolstra H
    Biol Blood Marrow Transplant; 2014 Jun; 20(6):752-9. PubMed ID: 24565991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
    Talmadge JE
    Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European group for blood and marrow transplantation.
    Baron F; Labopin M; Niederwieser D; Vigouroux S; Cornelissen JJ; Malm C; Vindelov LL; Blaise D; Janssen JJ; Petersen E; SociƩ G; Nagler A; Rocha V; Mohty M
    Leukemia; 2012 Dec; 26(12):2462-8. PubMed ID: 22699419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cells and acute graft-versus-host disease after allogeneic stem cell transplantation.
    Mohty M
    Leuk Lymphoma; 2007 Sep; 48(9):1696-701. PubMed ID: 17786704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory cytokines and dendritic cells in acute graft-versus-host disease after allogeneic stem cell transplantation.
    Mohty M; Gaugler B
    Cytokine Growth Factor Rev; 2008 Feb; 19(1):53-63. PubMed ID: 18083060
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.